*These authors contributed equally to this work. Supported by the intramural program of the National Institute on Alcohol Abuse and Alcoholism (B.G.) and the National Cancer Institute (H.A.Y.), and by the German Federal Ministry for Education and Research (BMBF) grants “Virtual Liver” and “Cell Therapy” (H.W., S.D.).
In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression†
Article first published online: 24 JUN 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 54, Issue 1, pages 252–261, July 2011
How to Cite
Park, O., Wang, H., Weng, H., Feigenbaum, L., Li, H., Yin, S., Ki, S. H., Yoo, S. H., Dooley, S., Wang, F.-S., Young, H. A. and Gao, B. (2011), In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology, 54: 252–261. doi: 10.1002/hep.24339
Potential conflict of interest: Nothing to report.
- Issue published online: 24 JUN 2011
- Article first published online: 24 JUN 2011
- Accepted manuscript online: 4 APR 2011 09:58AM EST
- Manuscript Accepted: 25 MAR 2011
- Manuscript Received: 29 NOV 2010
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.